New Study Suggests Surgery Before Chemotherapy for Patients with Aggressive Ovarian Cancer

Led by researchers at NYU Langone’s Perlmutter Cancer Center and Dana-Farber Cancer Institute, the study used a mathematical tool to examine how doctors should coordinate available treatments for high-grade serous ovarian cancer (HGSC).

New Study Suggests Surgery Before Chemotherapy for Patients with Aggressive Ovarian Cancer